Pharmacom Biovet Stock Analysis
| PHMB Stock | USD 0.0001 0.00 0.00% |
Pharmacom Biovet is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Pharmacom Biovet stock analysis is to determine its intrinsic value, which is an estimate of what Pharmacom Biovet is worth, separate from its market price. There are two main types of Pharmacom Biovet's stock analysis: fundamental analysis and technical analysis.
The Pharmacom Biovet stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Pharmacom Biovet's ongoing operational relationships across important fundamental and technical indicators.
Pharmacom |
Pharmacom Stock Analysis Notes
The company had not issued any dividends in recent years. Pharmacom Biovet had 1:15 split on the 10th of September 2008. PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States. PharmaCom BioVet, Inc. was incorporated in 1995 and is headquartered in Raleigh, North Carolina. PHARMACOM BIOVET operates under Medical Care Facilities classification in the United States and is traded on PNK Exchange. To find out more about Pharmacom Biovet contact the company at 919 604 4887.Pharmacom Biovet Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Pharmacom Biovet's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Pharmacom Biovet or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Pharmacom Biovet generated a negative expected return over the last 90 days | |
| Pharmacom Biovet has some characteristics of a very speculative penny stock | |
| Pharmacom Biovet has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (556.18 K) with profit before overhead, payroll, taxes, and interest of 0. |
Pharmacom Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.08 M.Technical Drivers
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharmacom Biovet, as well as the relationship between them.Pharmacom Biovet Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Pharmacom Biovet middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Pharmacom Biovet. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Pharmacom Biovet Outstanding Bonds
Pharmacom Biovet issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pharmacom Biovet uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pharmacom bonds can be classified according to their maturity, which is the date when Pharmacom Biovet has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US717265AM45 Corp BondUS717265AM45 | View | |
| FCX 7125 01 NOV 27 Corp BondUS717265AJ16 | View | |
| US717265AL61 Corp BondUS717265AL61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
About Pharmacom Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Pharmacom Biovet prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pharmacom shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pharmacom Biovet. By using and applying Pharmacom Stock analysis, traders can create a robust methodology for identifying Pharmacom entry and exit points for their positions.
PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States. PharmaCom BioVet, Inc. was incorporated in 1995 and is headquartered in Raleigh, North Carolina. PHARMACOM BIOVET operates under Medical Care Facilities classification in the United States and is traded on PNK Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Pharmacom Biovet to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Complementary Tools for Pharmacom Stock analysis
When running Pharmacom Biovet's price analysis, check to measure Pharmacom Biovet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacom Biovet is operating at the current time. Most of Pharmacom Biovet's value examination focuses on studying past and present price action to predict the probability of Pharmacom Biovet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacom Biovet's price. Additionally, you may evaluate how the addition of Pharmacom Biovet to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stocks Directory Find actively traded stocks across global markets |